Transmission and spreading of tauopathy in transgenic mouse brain

Nature Cell Biology

Volumn 11, Issue 7, 2009, Pages 909-913

  Clavaguera, Florence ^a   Bolmont, Tristan ^b   Crowther, R Anthony ^c   Abramowski, Dorothee ^d   Frank, Stephan ^a   Probst, Alphonse ^a   Fraser, Graham ^c   Stalder, Anna K ^e   Beibel, Martin ^d   Staufenbiel, Matthias ^d   Jucker, Mathias ^b   Goedert, Michel ^c   Tolnay, Markus ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^d NOVARTIS PHARMA AG   (Switzerland)

^e UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

TAU PROTEIN;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CAPSULA INTERNA; CEREBRAL PEDUNCLE; CONTROLLED STUDY; DISEASE SEVERITY; ENTORHINAL CORTEX; HIPPOCAMPAL FIMBRIA; HYPOTHALAMUS; MEDIAL LEMNISCUS; MOUSE; NONHUMAN; OPTIC TRACT; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PUTAMEN; SOMATOSENSORY CORTEX; SUBSTANTIA NIGRA; SUPERIOR COLLICULUS; TAUOPATHY; THALAMUS; TRANSGENIC MOUSE; ZONA INCERTA;

ANIMALIA; MUS; MUS MUSCULUS;

EID: 67650077008     PISSN: 14657392     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncb1901     Document Type: Article

References (35)

1. Goedert, M. & Spillantini, M. G. A century of Alzheimer's disease. Science 314, 777-781 (2006).
2. Braak, H. & Braak, E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82, 239-259 (1991).
3. Poorkaj, P. et al. Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann. Neurol. 43, 815-825 (1998).
4. Hutton, M. et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393, 702-705 (1998).
5. Spillantini, M. G. et al. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc. Natl Acad. Sci. USA 95, 7737-7741 (1998).
6. Allen, B. et al. Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein. J. Neurosci. 22, 9340-9351 (2002).
7. Probst, A. et al. Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein. Acta Neuropathol. 99, 469-481 (2000).
8. Frank, S., Clavaguera, F. & Tolnay, M. Tauopathy models and human neuropathology: Similarities and differences. Acta Neuropathol. 115, 39-53 (2008).
9. Goedert, M., Spillantini, M. G., Jakes, R., Rutherford, D. & Crowther, R. A. Multiple isoforms of human microtubule-associated protein tau: Sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 3, 519-526 (1989).
10. Gallyas, F. Silver staining of Alzheimer's neurofibrillary changes by means of physical development. Acta Morphol. Acad. Sci. Hung. 19, 1-8 (1971).
11. Braak, H., Braak, E., Ohm, T. & Bohl, J. Silver impregnation of Alzheimer's neurofibrillary changes counterstained for basophilic material and lipofuscin pigment. Stain Technol. 63, 197-200 (1988).
12. Lee, V. M.-Y., Goedert, M. & Trojanowski, J. Q. Neurodegenerative tauopathies. Annu. Rev. Neurosci. 24, 1121-1159 (2001).
13. Crowther, R. A. & Goedert, M. Abnormal tau-containing filaments in neurodegenerative diseases. J. Struct. Biol. 130, 271-279 (2000).
14. Prusiner, S. B. Prions. Proc. Natl Acad. Sci. USA 95, 13363-13383 (1998).
15. Legname, G. et al. Synthetic mammalian prions. Science 305, 673-676 (2004).
16. Kane, M. D. et al. Evidence for seeding of β-amyloid by intracerebral infusion of Alzheimer brain extracts in β amyloid precursor protein-transgenic mice. J. Neurosci. 15, 3606-3611 (2000).
17. Meyer-Luehmann, M. et al. Exogenous induction of cerebral β-amyloidosis is governed by agent and host. Science 313, 1781-1784 (2006).
18. Götz, J., Chen, F., van Dorpe, J. & Nitsch, R. M. Formation of neurofibrillary tangles in P301L tau transgenic mice induced by Aβ 42 fibrils. Science 293, 1491-1495 (2001).
19. Bolmont, T. et al. Induction of tau pathology by intracerebral infusion of amyloid-β-containing brain extract and by amyloid-β deposition in APP X tau transgenic mice. Am. J. Pathol. 171, 2012-2020 (2007).
20. Xing, Y. et al. Transmission of mouse senile amyloidosis. Lab. Invest. 81, 493-499 (2001).
21. Lundmark, K. et al. Transmissibility of systemic amyloidosis by a prion-like mechanism. Proc. Natl Acad. Sci. USA 99, 6979-6984 (2002).
22. Walker, L. C., LeVine III, H., Mattson, M. P. & Jucker, M. Inducible proteopathies. Trends Neurosci. 29, 438-443 (2006).
23. Boutajangout. et al. Characterisation of cytoskeletal abnormalities in mice transgenic for wild-type human tau and familial Alzheimer's disease mutants of APP and presenilin-1. Neurobiol. Dis. 15, 47-60 (2004).
24. Urushitani, M. et al. Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis. Nature Neurosci. 9, 108-118 (2006).
25. Asuni, A. A., Boutajangout, A., Quartermain, D. & Sigurdson, E. M. Immunotherapy targeting pathological tau conformers in a tangle mouse model reduces brain pathology with associated functional improvements. J. Neurosci. 27, 9115-9129 (2007).
26. Braak, H. et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging 24, 197-211 (2003).
27. Brundin, P., Li, J.-Y., Holton, J. L., Lindvall, O. & Revesz, T. Research in motion: The enigma of Parkinson's disease pathology spread. Nature Rev. Neurosci. 9, 741-745 (2008).
28. Brown, P. et al. Human spongiform encephalopathy: The National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann. Neurol. 35, 513-529 (1994).
29. Mercken, M. et al. Affinity purification of human tau proteins and the construction of a sensitive sandwich enzyme-linked immunosorbent assay for human tau detection. J. Neurochem. 58, 548-553 (1992).
30. Goedert, M., Jakes, R. & Vanmechelen, E. Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205. Neurosci. Lett. 189, 167-170 (1995).
31. Yoshida, H. & Goedert, M. Sequential phosphorylation of tau protein by cAMP-dependent protein kinase and SAPK4/p38δ or JNK2 in the presence of heparin generates the AT100 epitope. J. Neurochem. 99, 154-164 (2006).
32. Kosik, K. S. et al. Epitopes that span the tau molecule are shared with paired helical filaments. Neuron 1, 817-825 (1988).
33. Crowther, R. A. Straight and paired helical filaments in Alzheimer disease have a common structural unit. Proc. Natl Acad. Sci. USA 88, 2288-2292 (1991).
34. Goedert, M., Spillantini, M. G., Cairns, N. J. & Crowther, R. A. Tau proteins of Alzheimer paired helical filaments: Abnormal phosphorylation of all six brain isoforms. Neuron 8, 159-168 (1992).
35. Franklin, K. B. J. & Paxinos, G. The mouse brain in stereotaxic coordinates. (Academic Press, New York, 2001).